ʻO Melasma kekahi o nā pilikia puaʻa e hoʻopilikia nui ʻia. Hoʻi mai ia ma hope o ka laser, ʻā ia me ka lā a me nā hormones, a pinepine ʻole ia e pane i ka hydroquinone wale nō. ʻO ia ke kumu i neʻe ai ka tranexamic acid injection no ka keʻokeʻo ʻili a me ka mana melasma mai kahi ʻenehana niche i kahi noi maʻamau i nā hana aesthetic ma waena o Asia, Middle East a me ʻEulopa. Mālama kēia alakaʻi i ka hana ʻana o ka waikawa tranexamic (TXA) i ka puaʻa, ka mea i hōʻike maoli ʻia e ka ʻikepili lapaʻau i paʻi ʻia, pehea e holo maʻamau ai ka poʻe loea i kahi protocol TXA mesotherapy, a me nā mea hoʻolaha a me nā hōʻailona clinic e nānā ma mua o ka loaʻa ʻana o kahi formula TXA.
He aha ka Tranexamic Acid a no ke aha i hoʻohana ʻia ai ma ka ʻili?
ʻO ka waika Tranexamic kahi mea hoʻoheheʻe synthetic o ka amino acid lysine. Ua hoʻomohala mua ʻia ma ke ʻano he lāʻau antifibrinolytic, ʻo ia ka mea e hōʻemi i ke koko ma ke kāohi ʻana i ka hoʻololi ʻana o ka plasminogen i plasmin. Ua hoihoi ka poʻe Dermatologists iā ia ma hope o ka ʻike ʻana o ka poʻe noiʻi ʻo ka pale ʻana i ke ala plasminogen-plasmin i hōʻemi ʻia i ka pigmentation i hoʻokomo ʻia i ka ultraviolet.
I ka lāʻau lapaʻau aesthetic, hoʻohana ʻia ʻo TXA i ʻekolu mau ʻano nui:
ʻO nā serum a me nā creams topical , maʻamau i nā haʻahaʻa haʻahaʻa
ʻO nā papa waha , i kuhikuhi ʻia e nā kauka no ka melasma kūpaʻa
Intradermal microinjection (mesotherapy) , kahi i hoʻokomo pono ʻia ai kahi hopena dilute i loko o ka wahi pigmented.
Pehea ka Tranexamic Acid e hoemi ai i ka Pigmentation
ʻAʻole ʻo Melasma wale ka 'nui loa melanin'. Hoʻopili ia i ke kamaʻilio ʻana ma waena o kekahi mau ʻano cell i loko o ka ʻili. Eia ka mana maʻalahi o ka hoʻopau ʻana o TXA iā ia.
Kāohi i ka hōʻailona plasmin
Ke ʻike ʻia ka ʻili i ke kukui UV, hoʻopuka nā keratinocytes i ka mea hoʻoulu plasminogen. Hoʻokuʻu ʻo Plasmin i nā molekala hōʻailona e like me ka arachidonic acid a me nā prostaglandins, ka mea e koi ai i nā melanocytes e hoʻonui i ka melanin. Hoʻopaʻa ʻo TXA i ka hoʻoulu ʻana i ka plasminogen, no laila e nāwaliwali ka hōʻailona hoʻoulu i kona kumu.
Ke kuhi nei i ka ʻāpana vascular
Hōʻike pinepine nā maʻi melasma i nā kīʻaha koko liʻiliʻi ma mua o ka ʻili a puni, a ʻike ʻia nā mea ulu vascular e hānai i ka pōʻai puaʻa. Ma muli o ka hana pū ʻana o TXA ma ke ala plasmin e pili ana i ka angiogenesis, hiki ke kōkua i ka nānā ʻana i ka ʻulaʻula-ʻulaʻula o kekahi mau ʻāpana melasma. ʻO kēia kahi kumu i ʻokoʻa ai ka TXA mai nā mea hoʻopaneʻe tyrosinase maʻemaʻe.
No ke aha he mea nui kēia no ka koho lapaʻau
ʻO nā mea hoʻohui e like me ka glutathione, ka huaʻa C, ka kojic acid a me ka arbutin e hana nui i ka melanin synthesis ponoʻī. Hana ʻo TXA i luna, ma nā hōʻailona e hoʻomaka ai. ʻO ia ka mea i lilo i hoa pili pono ma mua o kahi pani. Inā makemake ʻoe i ka kikoʻī ma ka ʻaoʻao antioxidant, kā mākou ʻatikala ma ʻO ka glutathione a me ka ʻili keʻokeʻo ʻili e wehewehe i ka hopena o ka glutathione i ka puaʻa. ʻO ke koena o kēia alakaʻi e noho me TXA a me ka melasma.
ʻO ka mea i hōʻike ʻia e ka hōʻike lapaʻau
Ua aʻo ʻia ʻo TXA microinjection i nā hoʻāʻo loiloi ʻia e nā hoa, ʻoiai ʻo ka hapa nui he liʻiliʻi a wehe ʻia. ʻElua mau haʻawina i haʻi pinepine ʻia e hāʻawi i kahi kiʻi maoli:
ʻO Lee et al., Dermatologic Surgery (2006). Ma kahi haʻawina hoʻokele wehe he 12 pule o 100 mau wahine Korea me ka melasma, 0.05 mL o TXA (4 mg/mL) i hoʻopaʻa ʻia i loko o ka dermally ma 1 cm mau manawa hoʻokahi i ka pule. He kanawalukūmālima mau maʻi i hoʻopau i ke aʻo ʻana. Ua hāʻule ka mean Melasma Area and Severity Index (MASI) mai 13.22 ma ka baseline a i 7.57 i ka pule 12, a ua wehewehe ʻia nā hopena ʻaoʻao he liʻiliʻi.
Budamakuntla et al., Journal of Cutaneous and Aesthetic Surgery (2013). He kanaono mau maʻi i hoʻokaʻawale ʻia i TXA microinjections a i ʻole TXA i hāʻawi ʻia me ka microneedling, me ʻekolu mau mahina. Ua hoʻomaikaʻi ʻia ʻo MASI e 35.72% i ka hui microinjection a me 44.41% i ka hui microneedling, me ka hōʻike ʻole o nā hanana ʻino nui.
He aha kēia mau haʻawina e hōʻike nei:
Hiki i ka TXA mesotherapy ke ho'ēmi i ka nui o ka melasma ma mua o 8-12 mau pule.
ʻOkoʻa nā hopena. Ma ke aʻo ʻana iā Lee, ʻoi aku ka hapa nui o nā maʻi i ko lākou hoʻomaikaʻi ʻana ma ke ʻano he 'kūpono' (26-50% uila) ma mua o ka hoʻomaʻemaʻe piha ʻana.
He mea nui ke ala hoʻouna, a ʻo ka hui pū ʻana me ka microneedling hiki ke hoʻomaikaʻi i ke komo ʻana.
ʻAʻohe haʻawina e hōʻoia i ka ʻae mau loa. He maʻi maʻi ʻo Melasma, no laila pono e hōʻike nā kauka i ka TXA ma ke ʻano he mea mālama a mālama, ʻaʻole he lāʻau.
He TXA Mesotherapy Protocol maʻamau
ʻOkoʻa nā ʻokoʻa ma waena o nā mea hoʻomaʻamaʻa a me nā huahana, a pono e hahai kekahi papa hana lapaʻau i nā ʻōlelo aʻoaʻo o ka huahana no ka hoʻohana ʻana a me nā hoʻoponopono olakino kūloko. ʻO ke ʻano maʻamau i hoʻohana ʻia i nā keʻena lapaʻau e like me kēia.
Ke koho a me ka hoomakaukau ana
E hōʻoia i ka hōʻoia. ʻOkoʻa ka pane ʻana o ka Melasma, post-inflammatory hyperpigmentation a me nā lentigines solar.
ʻO ka pale no nā contraindications. Hoʻopilikia ka TXA i nā ala clotting, no laila he moʻolelo o ka thromboembolism, nā maʻi clotting, anticoagulant therapy a i ʻole ka hāpai ʻana e noi i ke kauka loiloi ma mua o ka mālama ʻana.
E paʻi kiʻi i ka wahi ma lalo o ka mālamalama mau, a e helu me ka MASI a i ʻole ka unahi like no ka hahai ʻana.
E hoʻomaʻemaʻe i ka ʻili a hoʻohana i ka anesthetic topical inā pono.
ʻenehana hoʻopio
Ka hohonu: hoʻokomo i loko o ke kino, ma kahi o 0.5-1 mm.
ʻO ka hakahaka a me ka leo: pāhaʻi liʻiliʻi liʻiliʻi i ka liona. Hoʻohana ʻia nā protocol i hoʻopuka ʻia ma kahi o 0.05 mL i kēlā me kēia kiko ma 1 knm manawa.
Mea hana hoʻouna: insulin syringe, meso gun, a i ʻole microneedling peni a me ka roller, ma muli o ka hoʻolālā huahana a me ka makemake o ke keʻena.
Kau pinepine
Ua hoʻohana ʻia nā haʻawina i paʻi ʻia i kēlā me kēia pule (Lee 2006) a i ʻole nā mahina (Budamakuntla 2013). Nui nā hoʻonā mesotherapy TXA pāʻoihana e paipai i hoʻokahi kau i kēlā me kēia pule ʻelua. ʻO ka papa hana maʻamau he 4-8 mau kau, a ma hope o nā mālama mālama e like me ka mea e pono ai.
Mahope o ka malama ana
E mālama pono i ka lā ākea ākea i kēlā me kēia lā. Inā ʻaʻole ia, e mae kekahi hoʻomaikaʻi.
E pale i ka wela, nā sauna a me nā mea hana ikaika no 24-48 mau hola.
E manaʻo i ka ʻulaʻula haʻahaʻa, ka ʻāʻī ʻana a i ʻole nā puʻupuʻu liʻiliʻi e kū mau i loko o hoʻokahi lā a ʻelua paha.
Hoʻohui ʻia ʻo TXA me nā mea hoʻomālamalama ʻē aʻe
Hoʻopili maikaʻi ʻia ka mīkini upstream o TXA me nā mea hana e hana i lalo o ke ala melanin. Hoʻohui pinepine ʻia nā ʻano hana hou i ka TXA me:
ʻO Glutathione a me ka huaʻa C no ke kākoʻo antioxidant a me ka pale ʻana i ka tyrosinase
Kojic acid, arbutin a i ʻole glycolic acid e kākoʻo i ka leo a me ka huli ʻana o ke kelepona
PDRN (polydeoxyribonucleotide) e kākoʻo i ka hoʻoponopono ʻana i ka ʻili a me ka hoʻihoʻi ʻana i ka pale, he mea nui ia no ka ʻili melasma paʻakikī a i ʻole i hōʻino ʻia e ka laser.
ʻO AOMA ʻO Tranexamic Acid Skin Whitening Injection me PDRN e hahai ana i kēia ʻano hana nui. Hoʻohui ia i ka PDRN, tranexamic acid, glutathione, glycolic acid, kojic acid a me ka huaora C i loko o 5 mL vials no ka hoʻohana intradermal. Hiki iā ʻoe ke hoʻohālikelike i nā mea hana ʻē aʻe i kā mākou piha ili whitening injection range.
Nā Manaʻo palekana
Loaʻa i ka Intradermal TXA kahi moʻolelo palekana maikaʻi i nā haʻawina i paʻi ʻia, akā pili mau ka hoʻohana kuleana i ka huahana a me ka mea hoʻomaʻamaʻa.
ka Sterility a me ka mana pyrogen no kekahi injectable. ʻAʻole hiki ke kūkākūkā ʻia ʻO nā huahana i hana maikaʻi ʻole ʻia ʻoi aku ka pilikia o ka honua maoli ma mua o ka mea hana pono.
ʻO nā hopena kūloko e like me ka erythema, ke ahi, ka ʻeha a me ka pehu liʻiliʻi ka hopena i hōʻike pinepine ʻia.
Kūkākūkā nui ʻia ka pilikia ʻōnaehana no ka TXA waha, e piʻi ana i ke kiʻekiʻe o ke koko. He hoʻomaʻamaʻa maikaʻi ka nānā ʻana no ka pilikia o ka clotting ma mua o ka hoʻoiho ʻana.
He ʻokoʻa ke kūlana hoʻoponopono ma ka ʻāina. Ma nā mākeke he nui, kūʻai ʻia nā hopena mesotherapy TXA ma ke ʻano he mea hoʻonaninani a i ʻole nā mea lāʻau lapaʻau ma mua o nā lāʻau lapaʻau. Pono nā kauka e nānā i nā lula kūloko ma mua o ka hoʻohana ʻana.
No ka ho'āʻoʻana i ka TXA Mesotherapy Solutions: He papa inoa no nā mea kūʻai aku a me nā hōʻailona Clinic
He ikaika ka noi no nā huahana TXA i nā mākeke me nā helu kiʻekiʻe o ka melasma, me ka Hikina Hema o Asia, ka Middle East, Latin America a me nā ʻāpana o ʻEulopa. Inā hoʻolālā ʻoe e hoʻokomo a hoʻopaʻa inoa pilikino i kahi ʻano TXA, e nānā:
ʻO ka moʻokalaleo ʻano: he papa inoa piha me nā manaʻo i ʻōlelo ʻia, ʻaʻole wale ʻo 'TXA complex'.
Nā kūlana hana: ISO 13485 a me GMP-compliant production, me nā moʻolelo pūʻulu.
Palapala: he palapala hōʻoia no ka nānā ʻana (COA), sterility a me nā hōʻike hoʻāʻo endotoxin, a me ka ʻikepili kūpaʻa a me ka mālama ola no kēlā me kēia pūʻulu.
Nā koho hoʻopili: ka nui o ka vial, ka nui o ka pahu a me ka hoʻopaʻa inoa ʻana i kūpono i nā koi hoʻopaʻa inoa o kāu mākeke.
Hoʻopilikino: inā hiki i ka mea hana ke hoʻoponopono i ka hui ʻana, no ka laʻana TXA me PDRN versus TXA me glutathione, no kou kūlana.
Kākoʻo ʻo AOMA i nā mea hoʻolaha a me nā hōʻailona clinic me ka hoʻopili ʻana, hoʻopiha a me ka hōʻailona inoa pilikino. E aʻo hou e pili ana i kā mākou nā hoʻonā OEM mesotherapy maʻamau.
FAQ
He mea pono anei ka waikini tranexamic no ka hoʻomaʻemaʻe ʻana i ka ʻili?
Hōʻike maikaʻi ʻia ʻo TXA ma ke ʻano he mea hoʻomalu i ka puaʻa ma mua o ka mea hana 'whitening'. Hōʻike nā haʻawina hoʻomaʻamaʻa hiki ke hōʻemi i ka paʻakikī o ka melasma a me ke kani ʻana, akā ʻaʻole ia e hoʻololi i ke kala ʻili maoli o ke kanaka.
Ehia mau manawa mesotherapy TXA e pono ai no ka melasma?
ʻO ka hapa nui o nā papa he 4-8 mau manawa i hoʻokaʻawale ʻia i hoʻokahi a ʻehā mau pule, e pili ana i ka protocol a me ka huahana. ʻIke ʻia ka hoʻomaikaʻi ʻana i nā haʻawina i paʻi ʻia ma kahi o 8-12 mau pule.
ʻOi aku ka maikaʻi o ka TXA mesotherapy ma mua o ka waika tranexamic waha?
Hana lākou i nā kumu like ʻole. ʻO Oral TXA kahi lāʻau lapaʻau me nā hopena ʻōnaehana a pono e nānā i ke kauka. Hāʻawi ka Intradermal TXA i kahi maʻi liʻiliʻi kūloko i ka lesion. Hiki i ka dermatologist ke hoʻohui i nā mea ʻelua no nā hihia kūpaʻa.
Hiki ke hoʻi mai ka melasma ma hope o ka mālama ʻana iā TXA?
ʻAe. ʻO ka Melasma ka maʻi a hoʻoulu ʻia e ka kukui UV, ka wela a me nā hormones. Pono ka mālama ʻana i ka lā i kēlā me kēia lā a me ka mālama ʻana i nā hopena.
Hiki ke hui pū ʻia ʻo TXA me ka laser a i ʻole ka peels?
Hoʻohana ka nui o nā loea i ka TXA me ka ʻili palupalu a i ʻole nā laser ikaika haʻahaʻa. Pono e hoʻokaʻawale ʻia nā lāʻau lapaʻau a hoʻolālā ʻia e kahi loea kūpono e pale aku i ka huhū a me ka hoʻihoʻi ʻana i ka pigmentation.
Nānā: Lee JH, Park JG, Lim SH, et al. ʻO ka microinjection intradermal kūloko o ka waikawa tranexamic no ka mālama ʻana i ka melasma i nā maʻi maʻi ʻĀsia: kahi hoʻokolohua mua. Dermatol Surg. 2006;32(5):626–631. Budamakuntla L, Loganathan E, Suresh DH, et al. A randomized, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling i nā maʻi me ka melasma. J Cutan Aeshet Surg. 2013;6(3):139–143.
No ka ʻike ʻoihana wale nō kēia ʻatikala a ʻaʻole ia he ʻōlelo aʻoaʻo olakino. Pono e hoʻokō ʻia nā lāʻau lapaʻau e nā loea kūpono e like me nā kānāwai kūloko.
ʻo Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) he kauka lapaʻau hoʻomaʻemaʻe i hōʻoia ʻia e ka papa ma New York City me ka ʻoi aku o 9 mau makahiki o ka ʻike kūikawā i ka hoʻopiha wai hyaluronic, ka mālama ʻana i ka maʻi ʻeha, a me ka liʻiliʻi o ka invasive o ka helehelena. Ua ʻike nui ʻia ʻo ia no kona akamai i nā lāʻau lapaʻau injectable holomua e hoʻomaʻamaʻa maikaʻi i nā ʻili ʻili, hoʻoikaika i ka hoʻōla ʻana o ka ʻili, a hoʻihoʻi hou i ka maʻalahi ma o ka hoʻoponopono ʻana i ka ʻili a me nā ʻenehana hoʻoikaika ʻili.
